07583272 · Active · incorporated 15 years, 6 months ago · London
Biotech Biotech & Life Sciences Drug Discovery Series A
Apterna is a preclinical biotechnology company developing precision RNA therapeutics to improve liver function in patients with advanced liver disease.
Apterna Limited is a private limited company registered at Companies House under number 07583272, incorporated on 29 March 2011, with a registered office in London. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 72 filings for this company, including 7 funding rounds. Its most recent round closed in February 2024, raising £50k.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 7 | Feb 2024 | £50k | £5.60 |
| Round 6 | Jul 2019 | £400k | £10.60 |
| Round 5 | Feb 2018 | £927k | £10.60 |
| Round 4 | Jun 2016 | £347k | £6.26 |
| Round 3 | Oct 2014 | £360k | £6.26 |
| Round 2 | Oct 2012 | £200k | £10,000.00 |
Showing the 6 most recent of 7 rounds.
Showing the 11 most recent of 72 filings.
See the complete cap table with every shareholder, founder tags, dilution across 13 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.